Clinical Trials Logo

Clinical Trial Summary

The purpose of the study is to evaluate the efficacy and safety of tirbanibulin 10 milligrams per gram (mg/g) ointment when applied to a treatment field (TF) larger than 25 centimeter square (cm^2) and up to 100 cm^2 in adult participants with actinic keratosis (AK).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06135415
Study type Interventional
Source Almirall, S.A.
Contact Davide Carluccio
Phone +34607245217
Email gco@almirall.com
Status Recruiting
Phase Phase 3
Start date December 21, 2023
Completion date December 2024

See also
  Status Clinical Trial Phase
Completed NCT03076892 - Evaluation of Non-inferiority and Tolerability of the Device PHOS-ISTOS N/A
Terminated NCT03076918 - Evaluating the Device FLEXITHERALIGHT Compared to the Conventional Photodynamic Therapy N/A
Completed NCT05356572 - A Pre-market Study to Evaluate the Performance and Safety of a Skin Preparation Device for Removal of Dry Crusty Skin N/A
Recruiting NCT05387525 - A Study of Tirbanibulin Ointment and Diclofenac Sodium Gel for the Treatment of Adult Participants With Actinic Keratosis on the Face or Scalp Phase 4
Completed NCT02594644 - The Use of Microneedles to Expedite Treatment Time in Photodynamic Therapy N/A
Active, not recruiting NCT02281682 - IM Versus 5-FU Versus IMI Versus MAL-PDT in Treatment of Actinic Keratosis Phase 4
Completed NCT01458587 - Levulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK) Phase 2
Completed NCT05260073 - Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis
Active, not recruiting NCT06014697 - OCT and Invasion in Cutaneous Skin Lesions
Completed NCT05279131 - A Study to Evaluate the Safety and Tolerability of Tirbanibulin Ointment 1% in Adult Participants With Actinic Keratosis Phase 3
Completed NCT05481073 - UV Sensor in Patients With Actinic Keratosis
Completed NCT03697590 - Photodynamic Therapy of Actinic Keratosis of the Face and Scalp With and Without Prior Curettage Phase 4
Withdrawn NCT02813902 - A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its Precursors Phase 1
Recruiting NCT05636800 - Microwave Treatment for Actinic Keratosis N/A
Completed NCT02628236 - Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2) Phase 2
Completed NCT02644187 - Pain Relief During Photodynamic Therapy for Actinic Keratoses With a New Irradiation Protocol N/A
Completed NCT02281136 - MUSE Study of Levulan Kerastick Phase 2
Completed NCT05060237 - Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp Phase 1
Terminated NCT04269395 - A Study to Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier Study Phase 3